Vitamin D3 Supplementation and Stress Fracture Occurrence in High-Risk Collegiate Athletes
NCT ID: NCT03395171
Last Updated: 2018-01-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
118 participants
INTERVENTIONAL
2015-11-30
2016-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This area of research is lacking in the quantity of prospective studies. Previous studies primarily focus on adolescent, elder, or military recruit populations. While literature has shown that vitamin D plays an important role in bone health, there are no previous studies that directly examine vitamin D deficiency and supplemental treatment in conditioned collegiate athlete populations. This study will add to the existing knowledge and will provide a more specific analysis for athletes.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Vitamin D Supplementation on Strength, Bone Density, and Injury Risk in Collegiate Athletes
NCT03151174
The Effect of Hypovitaminosis D and Vitamin D Supplementation on Fracture Nonunion Rates
NCT01691833
Vitamin D Supplementation and Tibia Fracture. Does it Improve Healing Rate?
NCT03232216
Vitamin D Supplement for Patients With Tibial Fracture
NCT01955577
Effects of Vitamin D on Skeletal Muscle Strength in Resistance Trained Adult Females
NCT05489666
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment: Cholecalciferol (Vitamin D3)
Athletes with Vitamin D levels lower than 30ng/mL will be treated with the supplement for eight weeks.
Cholecalciferol (Vitamin D3)
Supplementation of subjects who meet the inclusion criteria and test to have below the threshold of vitamin D in their blood.
Prospective Control Group
Athletes with Vitamin D levels higher than 30ng/mL were enrolled and compared but not treated.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cholecalciferol (Vitamin D3)
Supplementation of subjects who meet the inclusion criteria and test to have below the threshold of vitamin D in their blood.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Athlete recovering from a lower extremity musculoskeletal injury
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Prisma Health-Midlands
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
J. Benjamin Jackson III, MD
Role: PRINCIPAL_INVESTIGATOR
Prisma Health-Midlands
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00048420
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.